Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|January 20, 2009
Dasatinib in relapsed or plateau-phase multiple myelomaTanya M Wildes, Elizabeth Procknow, Feng Gao, et al.
Cancer|November 14, 2019
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare databaseBita Fakhri, Mark A Fiala, Nina Shah, et al.
Leukemia & Lymphoma|January 14, 2012
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005Jeevan Sekhar, Kristen Sanfilippo, Qin Zhang, et al.
Journal of Geriatric Oncology|July 3, 2019
Cost differential associated with hospice use among older patients with multiple myelomaMark A Fiala, Torie Gettinger, Cara L Wallace, et al.
Journal of Geriatric Oncology|March 15, 2020
The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myelomaMark A Fiala, Nicole C Foley, Sonja Zweegman, et al.
American Journal of Clinical Pathology|March 17, 2010
Molecular pathology of myeloproliferative neoplasmsJeffery M Klco, Ravi Vij, Friederike H Kreisel, et al.
Annals of Hematology|January 21, 2021
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world"Hira S Mian, Mark A Fiala, Larysa Sanchez, et al.
Journal of Geriatric Oncology|October 2, 2012
New Treatment Approaches for Older Adults with Multiple MyelomaTanya M Wildes, Ravi Vij, Stephen H Petersdorf, et al.
Haematologica|October 18, 2006
The activity and toxicity of low dose clofarabine against relapsed or refractory myelomaGeoffrey L Uy, Michael H Tomasson, Alisa Ruddell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic SyndromeMichael Slade, John F DiPersio, Peter Westervelt, et al.
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|January 20, 2009
Dasatinib in relapsed or plateau-phase multiple myelomaTanya M Wildes, Elizabeth Procknow, Feng Gao, et al.
Cancer|November 14, 2019
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare databaseBita Fakhri, Mark A Fiala, Nina Shah, et al.
Leukemia & Lymphoma|January 14, 2012
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005Jeevan Sekhar, Kristen Sanfilippo, Qin Zhang, et al.
Journal of Geriatric Oncology|July 3, 2019
Cost differential associated with hospice use among older patients with multiple myelomaMark A Fiala, Torie Gettinger, Cara L Wallace, et al.
Journal of Geriatric Oncology|March 15, 2020
The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myelomaMark A Fiala, Nicole C Foley, Sonja Zweegman, et al.
American Journal of Clinical Pathology|March 17, 2010
Molecular pathology of myeloproliferative neoplasmsJeffery M Klco, Ravi Vij, Friederike H Kreisel, et al.
Annals of Hematology|January 21, 2021
Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the "real world"Hira S Mian, Mark A Fiala, Larysa Sanchez, et al.
Journal of Geriatric Oncology|October 2, 2012
New Treatment Approaches for Older Adults with Multiple MyelomaTanya M Wildes, Ravi Vij, Stephen H Petersdorf, et al.
Haematologica|October 18, 2006
The activity and toxicity of low dose clofarabine against relapsed or refractory myelomaGeoffrey L Uy, Michael H Tomasson, Alisa Ruddell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic SyndromeMichael Slade, John F DiPersio, Peter Westervelt, et al.
Pageof 29